The data from the CDC's National Immunization Survey estimates that 37.6% of Americans ages 65 and older had gotten a shot of ...

If you haven’t gotten your flu or COVID-19 shot yet this season, Wisconsin health officials are urging people to do so ahead ...

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.

The acquisition was part of BioNTech's broader oncology strategy, backed by the financial success of its Covid-19 vaccine ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

Although it is seeing a downturn in sales and profits, German biotech BioNTech (Nasdaq: BNTX) is continuing to acquire assets ...

November 13th has seen a myriad of significant events throughout history, impacting various spheres such as politics, science ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

SkyQuest projects that the Vaccines market will attain a value of USD 99.85 billion by 2031, with a CAGR of 3.70% over the forecast period (2024-2031). Surging prevalence of chronic diseases and ...

At the height of the pandemic, the race was on for a COVID-19 vaccine that could save lives and hasten a ... In November 2020 ...

Geovax Labs, Inc. ( (GOVX) ) has released its Q3 earnings. Here is a breakdown of the information Geovax Labs, Inc. presented to its investors.